IRIS
FALASCA, KATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.428
EU - Europa 3.228
AS - Asia 1.367
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.413
IE - Irlanda 673
CN - Cina 638
IT - Italia 585
SE - Svezia 512
UA - Ucraina 507
TR - Turchia 346
GB - Regno Unito 285
FR - Francia 201
DE - Germania 173
IN - India 125
SG - Singapore 120
RU - Federazione Russa 106
FI - Finlandia 98
KR - Corea 86
VN - Vietnam 30
NL - Olanda 19
BE - Belgio 15
CZ - Repubblica Ceca 14
CA - Canada 11
RO - Romania 11
CH - Svizzera 7
HK - Hong Kong 7
AT - Austria 5
EU - Europa 4
IL - Israele 4
AR - Argentina 3
BR - Brasile 3
BG - Bulgaria 2
EE - Estonia 2
ES - Italia 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
MX - Messico 2
PL - Polonia 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CL - Cile 1
GT - Guatemala 1
JP - Giappone 1
KH - Cambogia 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
MY - Malesia 1
PA - Panama 1
PH - Filippine 1
TW - Taiwan 1
Totale 8.035
Salva come PNG Salva come JPEG
Città #
Chandler 780
Jacksonville 696
Dublin 656
Princeton 318
Southend 244
Nanjing 215
Izmir 195
Ashburn 176
Altamura 141
Chieti 109
Dearborn 108
Beijing 104
Wilmington 104
Cambridge 97
Ann Arbor 87
Boardman 74
Singapore 68
Nanchang 65
Shenyang 37
Pune 32
Dong Ket 30
New York 30
Hebei 27
Seattle 27
Tianjin 27
Washington 27
Jiaxing 25
Kunming 24
Woodbridge 24
Changsha 20
Hangzhou 19
Pescara 19
Dallas 17
Milan 17
Grevenbroich 16
Norwalk 16
Rome 16
Brussels 14
Los Angeles 14
Changchun 13
Jinan 13
Augusta 12
Brno 11
Helsinki 10
Moscow 10
Falls Church 9
Orange 8
San Mateo 8
San Vito Chietino 8
Tappahannock 8
Guangzhou 7
Lanzhou 7
Ningbo 7
Edinburgh 6
Hong Kong 6
Houston 6
Toronto 6
Hefei 5
Munich 5
Vienna 5
Albenga 4
Andover 4
Aquila 4
Auburn Hills 4
Leawood 4
London 4
Montesilvano 4
Pianella 4
Putignano 4
Chengdu 3
Chicago 3
Francavilla Al Mare 3
Gela 3
Giulianova 3
L'aquila 3
Lanciano 3
Molise 3
Monmouth Junction 3
Mumbai 3
Napoli 3
New Delhi 3
Olomouc 3
Redwood City 3
Simi Valley 3
Taranto 3
Venafro 3
Zhengzhou 3
Antalya 2
Baotou 2
Bari 2
Belgrade 2
Berazategui 2
Bronte 2
Civitanova Marche 2
Francavilla al Mare 2
Frankfurt am Main 2
Fuzhou 2
Jakarta 2
Kirkland 2
Malatya 2
Totale 5.001
Salva come PNG Salva come JPEG
Nome #
Study of immune alterations in patients with Chronic Fatigue Sindrome with different etiologies 98
Relevance of plant lectins in human cell biology and immunology 98
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 97
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 95
Metabolic modifications in HIV-infected women 92
STUDIO CLINICO MULTICENTRICO PER LA VALUTAZIONE DELLA MICROALBUMINURIA NEI PAZIENTI CON INFEZIONE DA HIV 90
The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects 89
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 88
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 88
Dual nucleoside therapy for HIV infection: analysis of results and factors influencing viral response and long term efficacy 86
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 86
Long term effect of telmisartan in HIV-positive male patients with high blood pressure 85
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 85
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 85
Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. 84
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 84
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 84
Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy 82
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 78
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: The D:A:D study 76
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting 76
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 75
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 74
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 74
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 72
Acute urinary retention due to HSV-1: a case report 72
Cardiac Toxicity Associated with HCV Direct Antiviral Agents 72
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 71
Hypertension in HIV: Management and Treatment 70
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 69
Beneficaial effects of telmisaratan in HIV+ diabetic insulin-dependent patient 69
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 68
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 68
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 67
Is the rate of virological failure to cART continuing to decline in recent calendar years? 67
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity 66
Interleukin-31: a new cytokine involved in inflammation of the skin 66
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 66
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen 66
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 66
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 65
High dose of erythropoietin in management of interferon/ribavirin induced anemia 65
Inguinal lymphadenopathy due to Bartonella henselae 65
Antiretroviral therapy management and rationalisation of available resources 65
Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients 64
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 64
Switch to rilpivirine improves diabetes in an elderly HIV-positive patient 64
Canakinumab in a subgroup of patients with COVID-19 64
Periodontitis and cytokine patterns in HIV positive patients 63
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 63
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis 63
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 63
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 63
Probiotics and anti-inflammatory processes in HIV infection: from Benchside Research to Bedside 63
Air and surface measurements of SARS-CoV-2 inside a bus during normal operation 63
Ruolo delle citochine nella patogenesi delle malattie infettive 62
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 61
Severe HIV-associated hypertriglyceridemia treated with rosuvastatin plus mega-3 fatty acids 60
Proteinuria in an African HIV-infected patient: effects of telmisartan. 60
Different strategies of 25OH vitamin D supplementation in HIV+ subjects. 60
Effectiveness of first-generation HCV protease inhibitors: does HIV coinfection still play a role? 60
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 60
Normal breathing releases SARS-CoV-2 into the air 60
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 59
Induction with ribavirin in a relapsing patient with chronic HCV hepatitis. 59
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 59
Correlation between neurocognitive disorders and pattern cytokines in HIV+ patients 59
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 59
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 59
IL-1beta induces alkaline phosphatase in human phagocytes 58
Infected atrial mixoma: a rare cause of fever 58
Esophagitis and anticonvulsant hypersensitivity syndrome. 58
Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men 58
IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances 57
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan. 56
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D: A: D study 56
Favourable evolution of virological and immunological profiles in treated and untreated patients in Italy in the period 1998-2008. 55
Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. 55
Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. 55
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 55
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 55
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 55
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 55
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 54
Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment. 54
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 54
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study 54
Effect of antiviral therapy on pro-angiogenic hematopoietic and endothelial progenitor cells in HIV-infected people. 54
BNT162b2 mRNA vaccination leads to long-term protection from COVID-19 disease 54
Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy. 53
Associations between immune depression and cardiovascular events in HIV infection. 53
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/m 53
Prevalence of HPV infection among HIV-positive and HIV-negative women in central/eastern Italy: Strategies of prevention 52
First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 52
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. 51
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study 51
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 50
Pidotimod and Immunological Activation in Individuals Infected with HIV 50
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 50
Use of direct renin inhibitor in an HIV positive subject. 49
Totale 6.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.674 500 98 26 34 139 109 180 138 82 169 173 26
2020/2021859 122 6 153 18 73 170 33 24 57 82 52 69
2021/2022773 27 24 11 157 46 17 30 57 57 28 80 239
2022/20232.316 208 360 139 241 205 439 131 174 252 27 67 73
2023/20241.157 76 50 84 42 100 326 262 58 9 19 12 119
2024/2025167 167 0 0 0 0 0 0 0 0 0 0 0
Totale 8.803